RXO (NYSE:RXO – Get Free Report) had its price objective dropped by analysts at Susquehanna from $16.00 to $12.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has a “negative” rating on the stock. Susquehanna’s target price points to a potential downside of 57.45% from the stock’s previous close.
RXO has been the topic of a number of other reports. Wells Fargo & Company reissued an “equal weight” rating and set a $31.00 target price on shares of RXO in a research report on Monday. TD Cowen lifted their target price on RXO from $23.00 to $28.00 and gave the stock a “hold” rating in a research report on Thursday, August 8th. UBS Group boosted their price target on RXO from $22.00 to $31.00 and gave the stock a “neutral” rating in a research note on Thursday, August 8th. Benchmark reiterated a “hold” rating on shares of RXO in a research note on Tuesday, October 15th. Finally, Jefferies Financial Group decreased their price target on shares of RXO from $33.00 to $31.00 and set a “buy” rating for the company in a research report on Tuesday, August 13th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $26.29.
Check Out Our Latest Research Report on RXO
RXO Trading Down 4.1 %
RXO (NYSE:RXO – Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.01. RXO had a negative net margin of 6.81% and a positive return on equity of 1.64%. The business had revenue of $1.04 billion for the quarter, compared to analyst estimates of $956.19 million. During the same quarter in the previous year, the business posted $0.05 EPS. The business’s quarterly revenue was up 6.6% on a year-over-year basis. Equities research analysts forecast that RXO will post 0.16 EPS for the current fiscal year.
Institutional Investors Weigh In On RXO
Several large investors have recently added to or reduced their stakes in the stock. Allspring Global Investments Holdings LLC grew its position in RXO by 2,235.3% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 3,643 shares of the company’s stock worth $80,000 after purchasing an additional 3,487 shares during the last quarter. Texas Permanent School Fund Corp increased its position in RXO by 1.3% in the 1st quarter. Texas Permanent School Fund Corp now owns 102,420 shares of the company’s stock valued at $2,240,000 after acquiring an additional 1,348 shares during the period. SG Americas Securities LLC bought a new stake in RXO during the 1st quarter valued at $151,000. Oppenheimer & Co. Inc. boosted its position in RXO by 11.2% during the 1st quarter. Oppenheimer & Co. Inc. now owns 21,207 shares of the company’s stock worth $464,000 after acquiring an additional 2,138 shares during the period. Finally, Oppenheimer Asset Management Inc. boosted its position in RXO by 24.8% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 24,962 shares of the company’s stock worth $546,000 after acquiring an additional 4,958 shares during the period. 92.73% of the stock is owned by institutional investors and hedge funds.
RXO Company Profile
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
See Also
- Five stocks we like better than RXO
- P/E Ratio Calculation: How to Assess Stocks
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- What does consumer price index measure?
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Industrial Products Stocks Investing
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.